8 ms·
As the article you're responding to details in one case FDA inspectors literally saw employees frantically destroying documents as they walked in. That factory
by iudqnolq 3y ago
As the article you're responding to details in one case FDA inspectors literally saw employees frantically destroying documents as they walked in. That factory was allowed to continue producing drugs. Empirical tests have shown certain factories manufactured drugs with insufficient concentration of the active ingredient. Those drugs are still on the market.
- alephnerd 3y agoValisure isn't a drug. It's regulated by the "Food Safety" division of the FDA. The FDA as an organization over-specializes on Biologics and Drug regulation at the expense of Food Regulation [0][1] and due to the "Food Safety" division's overlap with USDA. [0] - https://www.fda.gov/about-fda/fda-organization/fda-organization-charts https://www.fda.gov/about-fda/fda-organization/fda-organizat... [1] - https://www.politico.com/interactives/2022/fda-fails-regulate-food-health-safety-hazards/ https://www.politico.com/interactives/2022/fda-fails-regulat...
- iudqnolq 3y agoOf course Valisure isn't a drug. Valisure is the lab that tested the drug. What does that have to do wit- what I said?
- alephnerd 3y agoBECAUSE THE PORTION OF THE FDA THAT REFULATES DRUGS IS A DIFFERENT ORGANIZATION FROM THE ONE IN THE EXAMPLE YOU MENTIONED. I am talking about drug and biologics regulation. Not food safety.
- iudqnolq 3y agoValisure conducted a test of a regulated drug. Based on the results of Valisure's test we know the drug wasn't strong enough. That provides an example of an issue the current drug regulatatory scheme failed to catch. That suggests a problem with the current drug regulatory scheme. I don't know why you're talking about food safety.
- jqpabc123 3y agoEmpirical tests have shown certain factories manufactured drugs with insufficient concentration of the active ingredient. Basically, they are making more profit by selling a placebo. This is often the case with low cost generics. When the low cost generics are ineffective, doctors prescribe more expensive alternatives produced by the same manufacturer --- again they generate more profit.